LobbyingDendreon Pharmaceuticals lobbying by quarter
Dendreon Pharmaceuticals's latest lobbying report covers Q2 2026, at $89.7K. The four quarters Q4 2025–Q3 2026 total $268.9K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Medical/Disease Research/Clinical Labs.
Dendreon Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $269K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $182.2K | 3 |
| Q1 2023 | $183.9K | 3 |
| Q2 2023 | $183.9K | 3 |
| Q3 2023 | $184.2K | 3 |
| Q4 2023 | $184.2K | 3 |
| Q1 2024 | $107.5K | 2 |
| Q2 2024 | $108.1K | 2 |
| Q3 2024 | $108K | 2 |
| Q4 2024 | $107.6K | 2 |
| Q1 2025 | $90.1K | 2 |
| Q2 2025 | $88.8K | 2 |
| Q3 2025 | $89.7K | 2 |
| Q4 2025 | $89.7K | 2 |
| Q1 2026 | $89.7K | 2 |
| Q2 2026 | $89.7K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$968.1K · 12 reports
- Medicare and Medicaid$410K · 20 reports
- Veterans$239K · 7 reports
- Health issues$170K · 11 reports
- Taxation$80K · 6 reports
- Budget and appropriations$20K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES35 reports
- SENATE32 reports
- Executive Office of the President (EOP)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseDendreon Pharmaceuticals | $1.1M | 15 quarters |
| The McManus Group | $540K | 15 quarters |
| Federal Street Strategies | $200K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JOHN MCMANUS | LA, Bill Thomas. Staff Director, W&M Health Subcommittee | Q2 2026 |
| ALANNA TEMME | LD, Rep. Jon Porter | Q4 2023 |
| ANDREW JONES | Legislative Counsel, U.S. Representative Ruben Hinojosa; Legislative Director and Counsel, U.S. Representative Ben Ray Lujan | Q4 2023 |
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; Special Assistant, U.S. Secretary of Labor, Department of Labor. | Q4 2023 |
| RENE MUNOZ | Chief of Staff, U.S. Representative Xochitl Torres Small; Deputy Assistant USTR for Congressional Affairs; Chief of Congressional and Intergovernmental Affairs, U.S. Census Bureau; and Chief of Staff, U.S. Representative Pete Gallego. | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 09/09for Q2 | In-house | $59.7K |
| 07/20for Q2 | The McManus Group | $30K |
| 05/26for Q1 | In-house | $59.7K |
| 04/20for Q1 | The McManus Group | $30K |
| 02/25for Q4 2025 | In-house | $59.7K |
| 01/20for Q4 2025 | The McManus Group | $30K |
| 25/12/02for Q3 2025 | In-house | $59.7K |
| 25/10/20for Q3 2025 | The McManus Group | $30K |
| 25/08/19for Q2 2025 | In-house | $58.8K |
| 25/07/21for Q2 2025 | The McManus Group | $30K |
| 25/05/06for Q1 2025 | In-house | $60.1K |
| 25/04/21for Q1 2025 | The McManus Group | $30K |
| 25/02/06for Q4 2024 | In-house | $67.6K |
| 25/01/21for Q4 2024 | The McManus Group | $40K |
| 24/11/20for Q3 2024 | In-house | $68K |
| 24/10/21for Q3 2024 | The McManus Group | $40K |
| 24/08/06for Q2 2024 | In-house | $68.1K |
| 24/07/16for Q2 2024 | The McManus Group | $40K |
| 24/05/29for Q1 2024 | In-house | $67.5K |
| 24/04/22for Q1 2024 | The McManus Group | $40K |